EspañolIndiaItalianoFrançaisMy AccountMy AccountNotificationsOverview+ New WatchlistBenzinga ResearchBenzinga ProLog In-––%-––%-––%-––%-––%-––%-––%Get Benzinga Pro Data & APIsEventsMarketfyPremarketBoostAdvertiseContributeEspañolIndiaItalianoFrançaisSign inOur Services News EarningsGuidanceDividendsM&ABuybacksLegalInterviewsManagementOfferingsIPOsInsider TradesBiotech/FDAFreightPoliticsGovernmentHealthcareMarkets Pre-MarketAfter HoursMoversETFsForexCannabisCommoditiesOptionsBinary OptionsBondsFuturesCME GroupGlobal EconomicsPreviewsSmall-CapCryptocurrencyPenny StocksDigital SecuritiesVolatilityRatings Analyst ColorDowngradesUpgradesInitiationsPrice TargetIdeas Trade IdeasCovey Trade IdeasLong IdeasShort IdeasTechnicalsFrom The PressJim CramerRumorsBest Stocks & ETFsBest Penny StocksBest S&P 500 ETFsBest Swing Trade StocksBest Blue Chip StocksBest High-Volume Penny StocksBest Small Cap ETFsBest Stocks to Day TradeBest REITsYield How to Buy Corporate BondsHow to Buy Treasury BondsHow to Invest in Real Estate OnlineMoney Compare Online BrokersStock BrokersForex BrokersFutures BrokersCrypto BrokersOptions BrokersETF BrokersMutual Fund BrokersIndex Fund BrokersBond BrokersShort Selling BrokersStock AppsAll Broker ReviewsInsuranceAutoHomeMedicareLifeVisionDentalBusinessPetHealthMotorcycleRentersWorkers CompTop StocksPenny StocksStocks Under $5Stocks Under $10Stocks Under $20Stocks Under $50Stocks Under $100Alternative InvestingInvest in ArtInvest in WatchesInvest in LandInvest in Real EstateInvest in WineInvest in GoldMortgagesRefinancePurchaseFind a Mortgage BrokerAlts Alternative Investment PlatformsREITs Versus CrowdfundingHow to Invest in ArtworkHow to Invest in JewelryBest Real Estate Crowdfunding PlatformsBest Alternative InvestmentsBest Alternative Investment PlatformsCrypto Get StartedIs Bitcoin a Good Investment?Is Ethereum a Good Investment?What is BlockchainBest AltcoinsHow to Buy Cryptocurrency?DeFiCrypto and DeFi 101What is DeFi?Decentralized ExchangesBest DeFi Yield FarmsDigital SecuritiesNFTsNFT Release CalendarWhat is a Non-Fungible Token (NFT)?How to Buy Non-Fungible Tokens (NFTs)CryptoPunks WatchlistAre NFTs a Scam or a Digital Bubble?Best In CryptoBest Crypto AppsBest Crypto Portfolio TrackersBest Crypto Day Trading StrategiesBest Crypto IRABest Cryptocurrency ScannersBest Business Crypto AccountsBest Crypto ScreenersCannabis Cannabis ConferenceNewsEarningsInterviewsDealsRegulationsPsychedelicsJobs Ideas Trade IdeasCovey Trade IdeasLong IdeasShort IdeasTechnicalsFrom The PressJim CramerRumorsBest Stocks & ETFsBest Penny StocksBest S&P 500 ETFsBest Swing Trade StocksBest Blue Chip StocksBest High-Volume Penny StocksBest Small Cap ETFsBest Stocks to Day TradeBest REITsYield How to Buy Corporate BondsHow to Buy Treasury BondsHow to Invest in Real Estate OnlineMoney Compare Online BrokersStock BrokersForex BrokersFutures BrokersCrypto BrokersOptions BrokersETF BrokersMutual Fund BrokersIndex Fund BrokersBond BrokersShort Selling BrokersStock AppsAll Broker ReviewsInsuranceAutoHomeMedicareLifeVisionDentalBusinessPetHealthMotorcycleRentersWorkers CompTop StocksPenny StocksStocks Under $5Stocks Under $10Stocks Under $20Stocks Under $50Stocks Under $100Alternative InvestingInvest in ArtInvest in WatchesInvest in LandInvest in Real EstateInvest in WineInvest in GoldMortgagesRefinancePurchaseFind a Mortgage BrokerAlts Alternative Investment PlatformsREITs Versus CrowdfundingHow to Invest in ArtworkHow to Invest in JewelryBest Real Estate Crowdfunding PlatformsBest Alternative InvestmentsBest Alternative Investment PlatformsCrypto Get StartedIs Bitcoin a Good Investment?Is Ethereum a Good Investment?What is BlockchainBest AltcoinsHow to Buy Cryptocurrency?DeFiCrypto and DeFi 101What is DeFi?Decentralized ExchangesBest DeFi Yield FarmsDigital SecuritiesNFTsNFT Release CalendarWhat is a Non-Fungible Token (NFT)?How to Buy Non-Fungible Tokens (NFTs)CryptoPunks WatchlistAre NFTs a Scam or a Digital Bubble?Best In CryptoBest Crypto AppsBest Crypto Portfolio TrackersBest Crypto Day Trading StrategiesBest Crypto IRABest Cryptocurrency ScannersBest Business Crypto AccountsBest Crypto ScreenersCannabis Cannabis ConferenceNewsEarningsInterviewsDealsRegulationsPsychedelicsJobs ResearchMy StocksToolsCalendarsAnalyst Ratings CalendarConference Call CalendarDividend CalendarEarnings CalendarEconomic CalendarFDA CalendarGuidance CalendarIPO CalendarM&A CalendarSPAC CalendarStock Split CalendarTrade IdeasInsider TradesTrade Idea FeedAnalyst RatingsUnusual Options ActivityHeatmapsFree NewsletterShort InterestMost ShortedLargest IncreaseLargest DecreaseCalculatorsMargin CalculatorForex Profit Calculator100x Options Profit Calculator-––%-––%-––%-––%-––%-––%-––%Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Storiesby Vandana Singh, Benzinga Editor September 27, 2023 9:47 AM |  7 min read BenzingaAlibaba's Logistics Arm Cainiao Files For Hong Kong IPO
Alibaba Group Holding Limited BABA stock is trading higher Wednesday as the company's logistics arm Cainiao Smart Logistics Network Ltd filed for its Hong Kong initial public offering on Tuesday. The first-time share sale could fetch a minimum of $1 billion.
Alibaba co-founded Cainiao in 2013 as the delivery backbone for its Chinese online marketplaces. 
Qualcomm Gears Up for Innovation, Snapdragon 8 Gen 3 Set to Rival Apple's 3nm Chip Technology
Qualcomm Inc's QCOM Snapdragon 8 Gen 3 will arrive in 2 variants, one manufactured under Taiwan Semiconductor Manufacturing Company Ltd's TSM 4nm process and another manufactured under TSMC's 3nm process.
The leaked email conversations between Qualcomm and its smartphone partners like Samsung Electronics Co SSNLF indicate that the upcoming Qualcomm Snapdragon 8 Gen 3 will use Arm Holdings Plc's ARM latest Cortex X4, Cortex A720, and Cortex A520 CPU cores for its chipset CPU structure.
Weight Loss Drugs Like Wegovy Could Have Linked Anesthesia Complications, European Medicines Agency To Investigate
The European Medicines Agency (EMA) is set to address concerns related to patients taking drugs such as Novo Nordisk A/S's NVO Wegovy, Ozempic, and their counterparts potentially experiencing complications during anesthesia that could lead to pneumonia. 
The PRAC's discussions will also encompass other GLP-1 drugs, including Mounjaro and Trulicity by Eli Lilly And Co LLY and those made by AstraZeneca Plc AZN and Sanofi SA SNY.
Safety First: Target Shutters Nine Stores Amid Rising Retail Crime
Retail giant Target Inc TGT announced its decision to shutter nine stores spread over four states in the U.S., including the Golden State of California.
This move is in response to the increasing concerns about theft and structured retail crime, jeopardizing employee and customer safety.
Payroll Services Company Paychex' Q1: 7% Topline Growth, EPS Beat & More
Payroll services company Paychex Inc PAYX reported first-quarter FY24 sales growth of 7% year-on-year to $1.286 billion, slightly missing the analyst consensus estimate of $1.29 billion. Adjusted EPS of $1.14 beat the analyst consensus estimate of $1.12.
Paychex revised its FY24 adjusted EPS growth outlook from 9%-10% to 9%-11%.
 

Wall Street JournalHollywood Strike: Writers Secure Credit as Studios Retain AI Training Rights in New Deal
A tentative labor agreement between Hollywood studios and the Writers Guild of America (WGA) will likely allow studios to continue training artificial intelligence (AI) models using writers' works to the relief of the likes of Warner Bros. Discovery Inc WBD, Paramount Global PARA, Netflix Inc NFLX, and Walt Disney Co DIS.
However, writers will likely gain a significant victory, ensuring they receive both credit and compensation for their contributions, even when AI tools are employed. 
JPMorgan Settles Jeffrey Epstein Lawsuit With US Virgin Islands For $75M
JPMorgan Chase JPM has reached a $75 million settlement with the U.S. Virgin Islands to resolve allegations that the bank aided Jeffrey Epstein's sex trafficking activities.
This settlement comes ahead of the scheduled trial in Manhattan and follows nearly a year of legal battles.
 ReutersAI's Legal Challenge - Jury to Unravel Thomson Reuters and Ross Intelligence Dispute
Thomson Reuters Corp TRI will face Ross Intelligence in court, as a Delaware federal judge ruled that a jury should decide the lawsuit's outcome. 
Thomson Reuters accuses Ross Intelligence of unlawfully copying content from its legal research platform, Westlaw, to develop a competing AI-based platform.
Uncertainty Looms Over Pfizer's Oral COVID-19 Antiviral Pill - Doubts Over Commercial Approval
Pfizer Inc's PFE CEO Albert Bourla provided an update on the status of the company's oral antiviral COVID-19 treatment, Paxlovid, during his speech at the Cantor Fitzgerald Annual Healthcare Conference. 
Bourla revealed that approximately 250,000 courses of Paxlovid are being administered each week as the U.S. grapples with a surge in COVID-19 cases.
Global Consulting Firm McKinsey To Pay $230M In Opioid Lawsuit Settlements With US Local Governments
Consulting firm McKinsey & Company has reached a substantial settlement agreement of $230 million to resolve lawsuits filed by numerous U.S. local governments and school districts, accusing the firm of contributing to the opioid addiction crisis through its consulting work with OxyContin maker Purdue Pharma and other pharmaceutical companies. 
McKinsey had been accused of aiding drug manufacturers in devising deceptive marketing strategies and increasing the sales of opioid painkillers, thereby exacerbating the opioid crisis.
Migraine Medication Battle: Eli Lilly Prevails in Patent Infringement Case Against Teva
A federal judge in Massachusetts has overturned a $176.5 million jury verdict against Eli Lilly And Co LLY. The verdict, which had favored Teva Pharmaceutical TEVA, had found that Lilly's migraine drug, Emgality, infringed upon three patents related to Teva's rival drug, Ajovy.
 VergeApple Defends Its $19B Google Search Deal Even As It Laments Its Privacy Policies
Apple Inc's AAPL Eddy Cue defended the company's $19 billion deal with Alphabet Inc's GOOG GOOGL Google on a conflicting note – while he said Google Search was the best deal available for Apple, he also lamented the company's privacy policies.
Cue took the stand in the ongoing antitrust case against Google as he sought to justify Apple's $19 billion deal with the search giant, explaining that Google Search was the best option available and that there were no alternatives.
Warner, Roblox, Rivian And AMD CEOs Share Vision At The Code Conference 2023 - AI, Metaverse, And EVs Take Center Stage
The Code Conference 2023, a prominent tech event, is currently underway, featuring interviews with leading figures in the tech and business sectors. 
During the event, Warner Music Group Corp WMG CEO Robert Kyncl shared his perspective on the evolution of AI in music. He expressed optimism about integrating AI technologies in music creation and distribution shortly.
 InsiderAmazon Struggles To Clarify Return-to-Office Expectations
Peter DeSantis, the Senior Vice President of Utility Computing at Amazon.Com Inc AMZN, recently addressed concerns regarding the company's return-to-office (RTO) policy.
During an internal meeting, DeSantis acknowledged the challenges, pledged to improve communication, and handled cases where employees feel pressured to return prematurely.
 Financial TimesChina's Ambitious Chip Fund Faces Headwinds Amid Economic Challenges and US Restrictions
China's latest effort to bolster its semiconductor industry faces challenges in its initial stages, struggling to meet its RMB300 billion ($41 billion) target, with economic hardships cited as the primary reason. 
This funding round, the most ambitious by China, comes after Beijing approved a third round for the China Integrated Circuit Industry Investment Fund, commonly called the Big Fund.
Moderna Talks Offer Hope for Enhanced COVID-19 Vaccine Availability In Europe
European countries are actively negotiating a fresh COVID-19 vaccine procurement agreement with Moderna Inc MRNA as concerns mount within EU health authorities regarding a surge in coronavirus infections. 
Member states can express their interest in the deal individually, and at least eight EU countries have already shown interest in participating.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.Posted In: NewsTop StoriesMarketsGeneralPopular ChannelsPreMarket PrepPress ReleasesAnalyst RatingsNewsOptionsETFsTools & FeaturesReal Time FeedPublic RSS FeedsSubmit News TipsBlogEmbeddable Finance Widgets & ToolsBenzinga CatalystPartners & ContributorsAffiliate ProgramContributor PortalLicensing & SyndicationSponsored ContentAdvertise With UsLead Generation & SEOAbout BenzingaAbout UsCareersIn The NewsEventsContact UsTerms & Conditions  Do Not Sell My Personal Data/Privacy PolicyDisclaimer Service StatusSitemap© 2023 Benzinga | All Rights Reserved